Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
90587
First IPO Date
December 16, 1996
| Name | Title | Pay | Year Born |
| William N. Anderson | Chairman of the Management Board & Chief Executive Officer | 5.64M | 1966 |
| Julio Triana | Member of Management Board & President of Consumer Health Division | 2.09M | 1965 |
| Stefan Oelrich | Head of the Pharmaceuticals Division & Member of the Board of Management | 2.21M | 1968 |
| Judith Hartmann | Chief Financial Officer & Member of Management Board | 2.24M | 1969 |
| Wolfgang U. Nickl | Chief Financial Officer & Member of Management Board | 2.24M | 1969 |
| Rodrigo Santos | Member of Management Board, Head of the Crop Science Division & President of Crop Science Division | 2.28M | 1973 |
| Heike Prinz | Chief Talent Officer, Labor Director & Member of Management Board | 2.38M | 1964 |
| Michael Preuss | Head of Communications, Government Relations and Corporate Brand | 0 | N/A |
| Jost Reinhard | Senior Vice President & Head of Investor Relations | 0 | 1972 |
| Alex Buschermohle | Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division | 0 | N/A |
| Bill Dodero | General Counsel and Senior Vice President of Law Patents & Compliance | 0 | N/A |
Bayer AG, a global life sciences enterprise operating through its various subsidiaries, strategically organizes its operations into three key divisions: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division primarily focuses on prescription medications, predominantly addressing cardiovascular conditions and women's health. Additionally, it develops specialized therapies in areas like oncology, hematology, and ophthalmology, alongside offering diagnostic imaging equipment, contrast agents, and pioneering cell and gene therapies. Within the Consumer Health segment, the company provides a range of over-the-counter (OTC) remedies, medical devices, skincare products with medicinal properties, nutritional supplements, and general self-care solutions. These offerings cater to diverse health needs such as dermatological issues, dietary support, pain management, cardiovascular risk reduction, digestive well-being, allergy relief, and common cold and cough symptoms. The Crop Science segment is dedicated to agricultural innovation, supplying chemical and biological crop protection agents, enhanced plant varieties, seeds, digital tools, and solutions for pest and weed control. It also delivers crucial customer services to the farming community and is involved in the breeding, propagation, and processing of seeds, including specialized seed treatments. Bayer actively engages in numerous collaborations to advance its research and development pipeline. Key partnerships include an agreement with MD Anderson Cancer Center for developing oncology drugs, a research and license agreement with Dewpoint Therapeutics, Inc. focused on new treatments for cardiovascular and gynecological conditions, and collaborations with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG. Further alliances involve a research collaboration with Arvinas Inc., a strategic partnership with the University of Oxford for novel gynecological therapies, and a joint effort with Kyoto University to identify potential new drugs for pulmonary diseases. Its wide array of products reaches consumers through various channels, including wholesalers, pharmacies and pharmacy chains, supermarkets, online platforms, other retail outlets, hospitals, and direct sales to farmers. Established in 1863, the company's headquarters are situated in Leverkusen, Germany.